Johnson & Johnson (J&J) has faced legal setbacks both in the United States and India regarding its baby powder. J&J estimates its talc-related costs to be around $4.5 billion. These legal challenges reflect ongoing concerns and allegations regarding the safety of J&J’s baby powder.
A California jury has ordered Johnson & Johnson to pay $18.8 million in damages to a man who claims he developed cancer after using the company’s baby powder. The plaintiff, Emory Hernandez Valadez, alleged that his exposure to J&J’s talc-based products since childhood caused him to develop mesothelioma.
In India, the Food and Drug Administration (FDA) cancelled J&J’s license to manufacture and sell baby powder due to safety concerns, prompting an immediate recall of the product. The FDA raised issues regarding the pH level and its potential impact on infant skin and health.
J&J, facing lawsuits alleging asbestos contamination in its talcum powder, voluntarily surrendered its license in India. In the US, J&J’s subsidiary, LTL Management, filed for bankruptcy to settle thousands of talc-related lawsuits.
